Get the Stockscreener App
3.25
1.81%
-0.06
Pre-market:
3.03
-0.22
-6.77%
Adc Therapeutics Sa stock is traded at $3.25, with a volume of 421.03K.
It is down -1.81% in the last 24 hours and up +3.83% over the past month.
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
See More
Previous Close:
$3.31
Open:
$3.29
24h Volume:
421.03K
Relative Volume:
0.60
Market Cap:
$365.62M
Revenue:
$69.56M
Net Income/Loss:
$-240.05M
P/E Ratio:
-1.1017
EPS:
-2.95
Net Cash Flow:
$-121.90M
1W Performance:
+0.62%
1M Performance:
+3.83%
6M Performance:
+81.56%
1Y Performance:
+4.17%
1-Day Range:
$3.25
$3.372
1-Week Range:
$3.15
$3.38
52-Week Range:
$1.05
$3.97
Adc Therapeutics Sa Stock (ADCT) Company Profile
Name
Adc Therapeutics Sa
Sector
Industry
Phone
41 21 653 02 00
Address
BIOPOLE, EPALINGES
Compare ADCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
3.25 | 372.37M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Initiated | Stephens | Overweight |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-24 | Initiated | Guggenheim | Buy |
| Aug-10-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Apr-24-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-06-22 | Initiated | CapitalOne | Overweight |
| Nov-09-22 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-09-21 | Initiated | Wolfe Research | Outperform |
| Aug-17-21 | Resumed | Jefferies | Buy |
| Aug-09-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-03-20 | Initiated | Stifel | Hold |
| Oct-29-20 | Initiated | H.C. Wainwright | Buy |
| Jun-09-20 | Initiated | BofA/Merrill | Buy |
| Jun-09-20 | Initiated | Cowen | Outperform |
View All
Adc Therapeutics Sa Stock (ADCT) Latest News
Risk vs reward if holding onto ADC Therapeutics SABreakout Watch & Daily Stock Trend Watchlist - newser.com
Entry Recap: Is DRTSW in a long term uptrendMarket Growth Review & Fast Exit/Entry Strategy Plans - خودرو بانک
Price momentum metrics for ADC Therapeutics SA explainedWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
Is a relief rally coming for ADC Therapeutics SA holdersQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com
Leading companies in this space include Aadi Bioscience, - openPR.com
Quantitative breakdown of ADC Therapeutics SA recent moveTrade Risk Assessment & Advanced Swing Trade Entry Plans - newser.com
Is ADC Therapeutics SA trending in predictive chart modelsPortfolio Return Report & Low Volatility Stock Suggestions - newser.com
Understanding ADC Therapeutics SA’s price movementPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Price action breakdown for ADC Therapeutics SAWeekly Profit Report & Weekly Consistent Profit Watchlists - newser.com
IPO Launch: What drives ADC Therapeutics SAs stock price2025 Price Momentum & Weekly Top Performers Watchlists - خودرو بانک
ETF Watch: What hedge funds are buying Sealed Air CorporationTreasury Yields & Technical Pattern Recognition Alerts - خودرو بانک
Aug Patterns: Will ADC Therapeutics SA stock hit new highs in YEARStock Surge & Community Shared Stock Ideas - خودرو بانک
Valuation Update: What are Essential Utilities Incs recent SEC filings showingPortfolio Value Summary & Reliable Intraday Trade Alerts - خودرو بانک
Aug Update: Is ADC Therapeutics SA a stock for growth or value investorsJuly 2025 News Drivers & Long-Term Growth Plans - خودرو بانک
Does Qualys Inc have strong fundamentalsQuarterly Investment Review & Fast Entry Momentum Trade Alerts - خودرو بانک
ADC Therapeutics SA stock retracement – recovery analysis2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
ADC Therapeutics SA (NYSE:ADCT) Receives $7.75 Consensus Target Price from Brokerages - MarketBeat
ADC Therapeutics SA (NYSE:ADCT) Short Interest Update - MarketBeat
Invesco Ltd. Has $187,000 Holdings in ADC Therapeutics SA $ADCT - MarketBeat
Owning 30% shares,hedge funds owners seem interested in ADC Therapeutics SA (NYSE:ADCT), - Yahoo Finance
Nuveen LLC Makes New $214,000 Investment in ADC Therapeutics SA $ADCT - MarketBeat
Does ADC Therapeutics SA have a sustainable dividendWeekly Gains Summary & Technical Buy Zone Confirmation - Lancaster City Council
Can ADC Therapeutics SA weather a recession2025 Year in Review & Consistent Growth Equity Picks - 뉴스영
Has ADC Therapeutics SA formed a bullish divergenceJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
Real time pattern detection on ADC Therapeutics SA stockTrade Analysis Report & Fast Momentum Entry Tips - Newser
Is ADC Therapeutics SA stock influenced by commodity prices2025 Geopolitical Influence & Technical Pattern Recognition Alerts - خودرو بانک
Levels Update: Can ADC Therapeutics SA weather a recessionWeekly Gains Report & Safe Entry Zone Identification - خودرو بانک
Will breakout in ADC Therapeutics SA lead to full recovery2025 Short Interest & Long-Term Safe Investment Plans - Newser
Treasury Yields: Is INNV backed by strong institutional buying2025 Short Interest & Step-by-Step Swing Trade Plans - خودرو بانک
ADC Therapeutics SA recovery potential after sell offJobs Report & Momentum Based Trading Signals - Newser
What’s the RSI of ADC Therapeutics SA stock2025 EndofYear Setup & Daily Profit Focused Screening - خودرو بانک
News impact scoring models applied to ADC Therapeutics SAMarket Volume Summary & Consistent Return Investment Signals - Newser
Applying sector rotation models to ADC Therapeutics SA2025 Retail Activity & AI Forecasted Stock Moves - Newser
Using data models to predict ADC Therapeutics SA stock movementQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Can ADC Therapeutics SA hit a new high this month2025 Volatility Report & Fast Entry and Exit Trade Plans - Newser
Using data tools to time your ADC Therapeutics SA exit2025 Technical Overview & Real-Time Market Sentiment Alerts - Newser
ADC Therapeutics SA stock prediction for this weekMarket Growth Summary & Fast Gain Swing Trade Alerts - Newser
Aug Reactions: Is ADC Therapeutics SA part of any major indexQuarterly Earnings Summary & Consistent Profit Trading Strategies - خودرو بانک
Multi factor analysis applied to ADC Therapeutics SAQuarterly Market Summary & High Return Stock Watch Alerts - Newser
Measuring ADC Therapeutics SA’s beta against major indicesWeekly Gains Report & Smart Money Movement Tracker - Newser
Does ADC Therapeutics SA have consistent dividend growthTrade Volume Summary & High Conviction Investment Ideas - خودرو بانک
What is ADC Therapeutics SA’s book value per shareTreasury Yields & Accurate Intraday Trade Tips - خودرو بانک
Earnings visualization tools for ADC Therapeutics SAMarket Volume Summary & Safe Capital Growth Tips - Newser
What are ADC Therapeutics SA’s earnings expectationsTrade Risk Assessment & Fast Entry Momentum Alerts - خودرو بانک
Can technical indicators confirm ADC Therapeutics SA’s reversalTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
What institutional flow reveals about ADC Therapeutics SAWeekly Investment Report & Entry Point Confirmation Signals - Newser
Forecasting ADC Therapeutics SA price range with options dataTake Profit & Fast Entry High Yield Tips - Newser
Is ADC Therapeutics SA stock ready for a breakoutMarket Movement Recap & High Conviction Buy Zone Alerts - Newser
ADC Therapeutics SA stock trend outlook and recovery pathEarnings Overview Summary & Stock Portfolio Risk Management - Newser
Will earnings trigger a reversal in ADC Therapeutics SAQuarterly Performance Summary & Weekly Breakout Stock Alerts - Newser
Published on: 2025-09-03 02:44:03 - Newser
Adc Therapeutics Sa Stock (ADCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):